Key Market Indicator:
Stock market news: In short news style a la Twitter/X. Everything that is relevant - at a glance. The entry page for the informed investor. Compact, worth knowing and always up to date. Directly from the IR departments of the companies.
DE000A3MQR65
Tue, 29.07.2025
Viromed Medical AG
Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
Pinneberg, 29. July 2025 – Viromed Medical AG (Viromed; ISIN: DE000A3MQR65), a medical technology company and a pioneer in cold plasma technology, today successfully held its Annual General Meeting in virtual form. The shareholders approved all resolut [ … ]
Thu, 24.07.2025
Viromed Medical AG
Viromed Medical AG enters into a distribution partnership with TriPart for the market launch of ViroCAP® and PulmoPlas® in Turkey
Pinneberg, 24 July 2025 – Viromed Medical AG (Viromed; ISIN: DE000A3MQR65), a medical technology company and a pioneer in cold plasma technology, has entered into a new distribution partnership with TriPart TITAN GmbH & [ … ]
Mon, 30.06.2025
Viromed Medical AG
Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026
Pinneberg, June 30, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, expects dynamic sales growth in the coming financial years. In detail, revenue is expected to rise from EUR 1.37 milli [ … ]
Mon, 23.06.2025
Viromed Medical AG
Viromed Medical AG: Cold plasma technology shows potential to significantly reduce deaths in ventilated patients
Pinneberg, June 23, 2025 – Viromed Medical AG ("Viromed"; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology, has been informed by the Hannover Medical School (“Medizinische Hochschule Hannover“; MHH [ … ]
Fri, 06.06.2025
Viromed Medical AG
Viromed Medical AG plans change in the Supervisory Board and Chairman of the Supervisory Board
Pinneberg, June 06, 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer in cold plasma technology, proposes to the Annual General Meeting on July 29, 2025 that Dr. Thomas Gutschlag be elected [ … ]
Thu, 15.05.2025
Viromed Medical AG
Viromed Medical AG: Revolutionary cold plasma therapy for the treatment of ventilator-associated pneumonia (VAP) shows 100% efficacy in an in vitro study with MRSA and human lung cells (alveoli)
Study confirms the effectiveness and safety of cold plasma therapy
Pinneberg, May 14, 2025 - Viromed Medical AG ("Viromed", FSE: VMED; ISIN: DE000A3MQR65) [ … ]
Fri, 25.04.2025
Viromed Medical AG
Exclusive contract for ViroCAP® My Plasma with Landsberg First Class Aesthetic opens up Viromed's entry into the European cosmetics market
Pinneberg, April 25, 2025 - Viromed Medical AG ("Viromed", Ticker: VMED; ISIN: DE000A3MQR65), a medical device company and pioneer in cold plasma technology, and Landsberg First Class Aesthetic ("Landsberg"), [ … ]
Wed, 23.04.2025
Viromed Medical AG
Viromed Medical AG welcomes Dr. Thomas Gutschlag as new Investor
Pinneberg, April 23, 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in wound healing, intensive care medicine and air disinfection, has gained Dr. Thomas Gutschlag, founder [ … ]
Thu, 10.04.2025
Viromed Medical AG
Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use
Pinneberg, April 10. April 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in wound healing, intensiv [ … ]
Tue, 01.04.2025
Viromed Medical AG
Viromed Medical AG: UMECO Group acquires exclusive marketing rights in Asia for cold plasma medical devices ViroCAP® and PulmoPlas®
Pinneberg, 01. April 2025 - Viromed Medical AG ("Viromed", ticker: VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for applications in air disinfection, wound healing an [ … ]
